SCHEDULE: PAVmed Inc. Stakeholder Tasso Partners Reports 14.3% Ownership

Tasso Partners, LLC and Dana Carrera have amended their Schedule 13G filing to report a combined beneficial ownership of 14.3% of PAVmed Inc.'s common stock, totaling 914,246 shares.

Summary

• Tasso Partners, LLC and Dana Carrera (collectively, the "Reporting Persons") have filed an amended Schedule 13G, indicating their beneficial ownership of PAVmed Inc. common stock.
• The Reporting Persons collectively own 914,246 shares of PAVmed Inc. common stock.
• This represents 14.3% of the outstanding shares, based on 6,383,089 shares outstanding as of March 27, 2026.
• Tasso Partners, LLC holds 912,996 shares, and Dana Carrera holds an additional 1,250 shares.
• Dana Carrera indirectly controls Tasso Partners, LLC through Tasso Capital, LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily an update on ownership percentages rather than a disclosure of new strategic initiatives or financial performance.

Positives

• Significant ownership stake of 14.3% by Tasso Partners and Dana Carrera, indicating strong investor conviction.
• Clear reporting of beneficial ownership and voting power.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are typically made by institutional investors or individuals who acquire beneficial ownership of more than 5% of a company's voting stock. This filing indicates a significant passive stake in PAVmed Inc. by Tasso Partners and Dana Carrera.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant ownership, which can influence market perception and potential future corporate actions.

Key Dates

Keywords

PAVmed Inc., Schedule 13G, Tasso Partners, Dana Carrera, Beneficial Ownership, Common Stock, SEC Filing, Investment